← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2012Last known activity
Jan 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 11 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (22)
- NCT06187285Sponsor investigatorN/AJan 1, 2024
- NCT06187285Lead sponsorN/AJan 1, 2024
- NCT06098625Lead sponsorN/ANov 10, 2023
- NCT06098625Reponsible party - principal investigatorN/ANov 10, 2023
- NCT06095492Reponsible party - principal investigatorN/AOct 30, 2023
- NCT06060392Lead sponsorN/AOct 30, 2023
- NCT06060392Reponsible party - principal investigatorN/AOct 30, 2023
- NCT06095492Lead sponsorN/AOct 30, 2023
- NCT06035874Lead sponsorN/AOct 15, 2023
- NCT06035874Reponsible party - principal investigatorN/AOct 15, 2023
- NCT06035874Sponsor investigatorN/AOct 15, 2023
- NCT05457933Lead sponsorPhase 4Jul 29, 2022
- NCT05457933Reponsible party - principal investigatorPhase 4Jul 29, 2022
- NCT05036876Reponsible party - principal investigatorN/AOct 10, 2021
- NCT05036876Lead sponsorN/AOct 10, 2021
Details
- Last known activity
- Jan 1, 2024